Dipender is a clinician scientist, who trained in Medical Sciences at the University of Oxford and was awarded Distinction for his BM BCh. He went on to become a specialist registrar in clinical pharmacology and therapeutics at Imperial College Healthcare NHS Trust, and in 2013 became an Honorary Clinical Lecturer at Imperial College London. Most recently, Dipender has followed his research interests in Mendelian randomisation to identify causal risk factors and therapeutic targets for cardiovascular diseases, successfully defending his PhD thesis in Dec 2019. He has over 50 peer-reviewed manuscripts including 16 first author papers from his PhD. This includes work identifying genetic variants to proxy the effect of antihypertensive, anticoagulant and anti-inflammatory drugs.
Tsilidis K, 2022, Circulating inflammatory cytokines and risk of five cancers: a mendelian randomization analysis, Bmc Medicine, Vol:20, ISSN:1741-7015
et al., 2022, Morning Cortisol and Circulating Inflammatory Cytokine Levels: A Mendelian Randomisation Study, Genes, Vol:13, Pages:116-116
et al., 2022, Maternal hypertension increases risk of pre-eclampsia and low fetal birthweight: genetic evidence from a Mendelian randomization study, Hypertension, ISSN:0194-911X
et al., 2022, Sleep disordered breathing, obesity and atrial fibrillation: a mendelian randomisation study, Geneses, Vol:13, ISSN:1155-3219, Pages:1-11